Gastrointestinale forstyrrelser er oftest rapporteret (10 til 100% af patienterne) og er reversible, når dosis bliver reduceret.
Gastrointestinal disorders are the most frequently reported (10 to 100% of patients) and are reversible when the dose is reduced.